INTRODUCTION: Substantial increases in body weight can be induced by several antipsychotic drugs, most notably olanzapine and clozapine. Antagonism at certain receptors, particularly 5-HT2C and histamine H1 receptors, is implicated in this effect. MATERIALS AND METHODS: We have investigated the contribution of effects at these receptors to olanzapine-induced weight gain occurring over 5 days following daily intraperitoneal drug injections in groups of eight female rats. RESULTS: Olanzapine (2 mg/kg) and the 5-HT2C antagonist SB 243213 (1 mg/kg), but not the histamine H1 antagonist mepyramine (1 mg/kg), produced significant increases in percentage body weight above vehicle; olanzapine showed a significantly greater effect than SB 243213. Haloperidol (0.1 mg/kg) alone or with mepyramine had no significant effects on weight gain, while with SB 243213 and with both SB 243213 and mepyramine, it showed olanzapine-like increases in weight. CONCLUSION: These results suggest that 5-HT2C receptor antagonism or inverse agonism, in the presence of D2 receptor antagonism, may contribute to olanzapine-induced weight gain.
INTRODUCTION: Substantial increases in body weight can be induced by several antipsychotic drugs, most notably olanzapine and clozapine. Antagonism at certain receptors, particularly 5-HT2C and histamine H1 receptors, is implicated in this effect. MATERIALS AND METHODS: We have investigated the contribution of effects at these receptors to olanzapine-induced weight gain occurring over 5 days following daily intraperitoneal drug injections in groups of eight female rats. RESULTS:Olanzapine (2 mg/kg) and the 5-HT2C antagonist SB 243213 (1 mg/kg), but not the histamine H1 antagonist mepyramine (1 mg/kg), produced significant increases in percentage body weight above vehicle; olanzapine showed a significantly greater effect than SB 243213. Haloperidol (0.1 mg/kg) alone or with mepyramine had no significant effects on weight gain, while with SB 243213 and with both SB 243213 and mepyramine, it showed olanzapine-like increases in weight. CONCLUSION: These results suggest that 5-HT2C receptor antagonism or inverse agonism, in the presence of D2 receptor antagonism, may contribute to olanzapine-induced weight gain.
Authors: D W Bonhaus; K K Weinhardt; M Taylor; A DeSouza; P M McNeeley; K Szczepanski; D J Fontana; J Trinh; C L Rocha; M W Dawson; L A Flippin; R M Eglen Journal: Neuropharmacology Date: 1997 Apr-May Impact factor: 5.250
Authors: A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen Journal: Psychopharmacology (Berl) Date: 1996-03 Impact factor: 4.530
Authors: M D Wood; C Reavill; B Trail; A Wilson; T Stean; G A Kennett; S Lightowler; T P Blackburn; D Thomas; T L Gager; G Riley; V Holland; S M Bromidge; I T Forbes; D N Middlemiss Journal: Neuropharmacology Date: 2001-08 Impact factor: 5.250
Authors: M J Fell; N Anjum; K Dickinson; K M Marshall; L M Peltola; S Vickers; S Cheetham; J C Neill Journal: Psychopharmacology (Berl) Date: 2007-06-21 Impact factor: 4.415
Authors: Caleb C Lord; Steven C Wyler; Rong Wan; Carlos M Castorena; Newaz Ahmed; Dias Mathew; Syann Lee; Chen Liu; Joel K Elmquist Journal: J Clin Invest Date: 2017-08-14 Impact factor: 14.808